These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12931442)

  • 21. Fibrillary glomerulonephritis associated with essential thrombocytosis.
    Asaba K; Tojo A; Onozato ML; Mimura N; Kido M; Goto A; Endo H; Fujita T
    Clin Exp Nephrol; 2003 Dec; 7(4):296-300. PubMed ID: 14712360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous occurrence of fibrillary glomerulonephritis and renal lesions in nonmalignant monoclonal IgM gammopathy.
    Wu CK; Leu JG; Yang AH; Tarng DC; Tung HY; Chiang SS
    BMC Nephrol; 2016 Feb; 17():17. PubMed ID: 26892336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fibrillary glomerulonephritis].
    Rysavá R; Merta M; Zabka J; Reiterová J; Ríhová Z; Tesar V
    Sb Lek; 2003; 104(1):85-93. PubMed ID: 14577139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotactoid glomerulopathy in a child with Down syndrome.
    Takemura T; Yoshioka K; Akano N; Michihata I; Okada M; Maki S; Shigematsu H
    Pediatr Nephrol; 1993 Feb; 7(1):86-8. PubMed ID: 8439490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
    Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD
    Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic non-amyloidotic fibril deposition disease: a probable variant form of fibrillary glomerulonephritis.
    Soma J; Sato K; Nakaya I; Yahata M; Sakuma T; Sato H
    Clin Nephrol; 2011 Jan; 75(1):74-9. PubMed ID: 21176754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrillary nonamyloid glomerulonephritis: a rare etiology of nephrotic syndrome].
    Grosch S; Van Overmeire L; Krzesinski JM; Bovy C
    Nephrol Ther; 2011 Nov; 7(6):494-8. PubMed ID: 21498141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features.
    Alpers CE; Rennke HG; Hopper J; Biava CG
    Kidney Int; 1987 Mar; 31(3):781-9. PubMed ID: 3106698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrillary glomerulonephritis with splenic involvement: a detailed autopsy study.
    Satoskar AA; Calomeni E; Nadasdy G; Tozbikan G; Hitchcock C; Hebert L; Nadasdy T
    Ultrastruct Pathol; 2008; 32(3):113-21. PubMed ID: 18570157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerulopathies with fibrillary deposits.
    King JA; Culpepper RM; Corey GR; Tucker JA; Lajoie G; Howell DN
    Ultrastruct Pathol; 2000; 24(1):15-21. PubMed ID: 10721148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrillary glomerulonephritis and pulmonary hemorrhage in a patient with renal transplantation.
    Calls Ginesta J; Torras A; Ricart MJ; Ramirez J; Campo E; Darnell A; Andreu J; Revert L
    Clin Nephrol; 1995 Mar; 43(3):180-3. PubMed ID: 7774075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.
    Fogo A; Qureshi N; Horn RG
    Am J Kidney Dis; 1993 Sep; 22(3):367-77. PubMed ID: 8372831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathology and differential diagnosis of immunotactoid glomerulopathy].
    Sun XL; Zhang FC; Xiao Y; Liu L; Guan Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):703-706. PubMed ID: 27760612
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fibrillary glomerulonephritis. Case report for differential nephrotic syndrome diagnosis].
    Weiss M; Tzavella K; Müller-Höcker J; Nerlich A; Held E
    Pathologe; 1998 Feb; 19(2):141-5. PubMed ID: 9556799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases.
    Said SM; Rocha AB; Royal V; Valeri AM; Larsen CP; Theis JD; Vrana JA; McPhail ED; Bandi L; Safabakhsh S; Barnes C; Cornell LD; Fidler ME; Alexander MP; Leung N; Nasr SH
    Am J Kidney Dis; 2021 Mar; 77(3):454-458. PubMed ID: 32711071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillary glomerulonephritis and immunotactoid glomerulopathy.
    Alpers CE; Kowalewska J
    J Am Soc Nephrol; 2008 Jan; 19(1):34-7. PubMed ID: 18045849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of monoclonal gammopathy-related glomerulonephritis in renal allograft.
    Cadnapaphornchai P; Sillix D
    Clin Nephrol; 1989 Mar; 31(3):156-9. PubMed ID: 2650937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotactoid glomerulopathy.
    Korbet SM; Schwartz MM; Rosenberg BF; Sibley RK; Lewis EJ
    Medicine (Baltimore); 1985 Jul; 64(4):228-43. PubMed ID: 4010500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features.
    Bridoux F; Hugue V; Coldefy O; Goujon JM; Bauwens M; Sechet A; Preud'Homme JL; Touchard G
    Kidney Int; 2002 Nov; 62(5):1764-75. PubMed ID: 12371978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab treatment of fibrillary glomerulonephritis.
    Collins M; Navaneethan SD; Chung M; Sloand J; Goldman B; Appel G; Rovin BH
    Am J Kidney Dis; 2008 Dec; 52(6):1158-62. PubMed ID: 18823685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.